Related Experiment Video
Updated: May 30, 2025
11:22
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
27.7K
Ferroptosis: A New Pathway in the Interaction between Gut Microbiota and Multiple Sclerosis
Junjie Jian1,2, Jun Wei1,2
1The First College of Clinical Medical Science, China Three Gorges University, 443000 Yichang, Hubei, China.
Frontiers in Bioscience (Landmark Edition)
|January 25, 2025
Summary
Multiple sclerosis (MS) involves neuroinflammation and neuronal damage. New research explores how ferroptosis (iron-dependent cell death) and gut microbiota interactions influence MS, suggesting novel therapeutic targets.
Area of Science:
- Neuroscience
- Immunology
- Microbiology
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease characterized by neuroinflammation, demyelination, and neuronal damage.
- Emerging evidence links iron-dependent cell death (ferroptosis) and gut microbiota alterations to MS pathophysiology.
- Ferroptosis, involving lipid peroxidation and iron metabolism, contributes significantly to oxidative stress in MS.
Purpose of the Study:
- To investigate the intricate relationship between gut microbiota dysbiosis, ferroptosis, and their collective impact on multiple sclerosis.
- To highlight the potential of targeting the ferroptosis-gut microbiota axis for novel therapeutic interventions in MS.
- To synthesize current mechanistic pathways and clinical evidence for future research and personalized treatment strategies.
Main Methods:
- Review and integration of existing literature on ferroptosis, gut microbiota, and multiple sclerosis.
- Examination of mechanistic pathways linking iron metabolism, lipid peroxidation, and microbial metabolites to neuroinflammation.
- Analysis of clinical evidence and potential for microbiota profiling in MS treatment.
Main Results:
- Gut microbiota dysbiosis can influence systemic immunity and iron homeostasis, thereby modulating ferroptotic pathways relevant to MS.
- Ferroptosis, driven by oxidative stress and iron dysregulation, is implicated in the neurodegenerative processes of MS.
- The interplay between gut microbiota and ferroptosis presents a promising avenue for therapeutic modulation in MS.
Conclusions:
- Targeting the gut microbiota-ferroptosis axis offers a novel therapeutic strategy for multiple sclerosis.
- Personalized treatment approaches for MS may be developed based on individual gut microbiota profiles and ferroptosis markers.
- Further research into microbial contributions to ferroptosis is crucial for advancing MS treatment and understanding disease mechanisms.
